This article was originally published in The Rose Sheet
Depilatory and skin care sales up 3% to $27.5 mil. in second quarter, firm reports in 10Q filed with the Securities and Exchange Commission Aug. 8. Increase is led by 14% gain in Nair sales for the period (1"The Rose Sheet" Aug. 12, 2002, p. 5). Sales for smallest Armkel product category, oral care (Pearl Drops), soared 21% to $8.9 mil. for quarter. Results for the 50/50 Church and Dwight/Kelso & Co. partnership formed to purchase most Carter-Wallace consumer products are compared to C-W for previous year. Armkel total net sales advanced 1.8% to $115.9 mil. in Q2...
You may also be interested in...
Retail sales for Nair depilatories advanced 14% in the second quarter with the addition of new wax products, Church & Dwight reported Aug. 5
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.
Heading into an advisory committee review, agency suggests belantamab’s risks of keratopathy and other ocular issues have not been fully characterized and questions whether the proposed mitigation measures, including dosing modifications, are adequate.